In Brazil, CPG Companies Must Think Outside the Box to Dodge Supply Chain Challenges
Apr 14, 2017 04:01 am UTC| Business
SO PAULO, Brazil, April 14, 2017 -- Brazil’s vast geography, complex tax system, and end-of-the-month demand spikes create major challenges for consumer packaged goods (CPG) companies—challenges that require...

Five myths about dismantling North Sea oil rigs
Apr 14, 2017 03:14 am UTC| Insights & Views Business
Oil giant Royal Dutch Shell is under fire from environmental groups over its proposal to decommission the Brent oilfield in the North Sea. The plans submitted to the government relate to four concrete and steel platforms...

How United Airlines broke two golden rules of marketing
Apr 14, 2017 03:11 am UTC| Insights & Views Business
When they had passenger David Dao forcibly removed from an internal flight in the US, staff at United Airlines apparently forgot two golden rules of marketing. 1. Dont let your customers get hurt Dao was asked to...

Punked? How an upstart brewing company sold up and sold out
Apr 14, 2017 02:10 am UTC| Insights & Views Business
Want to be a multi-millionaire? Well then, start a rebel business, generate brand controversy and then sell it to the capitalists you appeared to despise. Thats one way to do it. Scottish multinational brewery,...
How social media turned United's PR flub into a firestorm
Apr 14, 2017 01:35 am UTC| Insights & Views Business
Recent PR stumbles by United Airlines and Uber illustrate the challenges for businesses in an age when citizen activism is amplified by social media. Incidents that not so long ago would have been relatively isolated are...
Wynn Resorts, Limited to Join the NASDAQ-100 Index Beginning April 24, 2017
Apr 14, 2017 00:00 am UTC| Business
NEW YORK, April 13, 2017 -- Nasdaq (Nasdaq:NDAQ) today announced that Wynn Resorts, Limited (Nasdaq:WYNN), will become a component of the NASDAQ-100 Index® (Nasdaq:NDX) and the NASDAQ-100 Equal Weighted Index...
Funding From Alzheimer’s Drug Discovery Foundation Advances M3 Biotechnology Toward Human Trials
Apr 14, 2017 00:00 am UTC| Business
SEATTLE, April 13, 2017 -- As the first investor in M3 Biotechnology, the Alzheimer’s Drug Discovery Foundation (ADDF) helped validate the therapeutic potential of M3’s drug candidate for Alzheimer’s disease. With a...